Hereditary Angioedema Latest Advances

Expanding the Diagnostic Lens: Mast Cell Activation Syndromes and the Hidden Spectrum of Angioedema Associated Mortality in COVID-19.

Journal: Academic forensic pathology

Published: January 19, 2026

Donidalorsen (Dawnzera) for prevention of hereditary angioedema attacks.

Journal: The Medical letter on drugs and therapeutics

Published: January 08, 2026

Garadacimab-gxii-A Novel Prophylactic Treatment for Hereditary Angioedema: A Drug Review.

Journal: The Annals of pharmacotherapy

Published: January 07, 2026

Correction to "Pharmacological Suppression of the Kallikrein Kinin System with KVD900: An Orally Available Plasma Kallikrein Inhibitor for the On-demand Treatment of Hereditary Angioedema".

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: December 29, 2025

Therapeutic Potential of C1-Inhibitor in Vascular Diseases and Beyond.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: December 18, 2025

Long-term Prophylaxis With Lanadelumab in Patients With Angioedema Due to C1 Inhibitor Deficiency: A Real-life Study in Spain.

Journal: Journal of investigational allergology & clinical immunology

Published: December 03, 2025

A Comprehensive Assessment of Health-Related Quality of Life in Hereditary Angioedema as a Patient-Centered Approach.

Journal: International archives of allergy and immunology

Published: November 28, 2025

Lanadelumab in Hereditary Angioedema: Real-World Outcomes and Implications for Access Practices in Europe.

Journal: Journal of clinical medicine

Published: November 25, 2025

Abdominal Pain Attacks and Angioedema in a Patient With a Homozygous MEFV Mutation: Concurrent FXII Hereditary Angioedema.

Journal: Journal of investigational allergology & clinical immunology

Published: November 24, 2025

Non-peptide bradykinin B2 receptor ligands possessing the substituted quinolinyl moiety: pharmacological properties and prospective clinical uses.

Journal: Peptides

Published: November 18, 2025

Patient-reported disease burden and health care utilization of HAE-nl-C1INH: insights from a real-world survey.

Journal: Clinical and experimental medicine

Published: November 14, 2025

Garadacimab (Andembry) for hereditary angioedema prophylaxis.

Journal: The Medical letter on drugs and therapeutics

Published: November 05, 2025